Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Parkinson disease”

ATR 1072 in Participants With PRKAG2 SyndromeNot Yet Recruiting
NCT07738107Phase 1, Phase 2Updated Jul 31, 2026
Sponsor: Atrium Therapeutics
Cardiac Glycogenosis · Cardiomyopathy · Hypertrophic · Wolff-Parkinson-White Syndrome
Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's DiseaseRecruiting
NCT07207122NAUpdated Jul 31, 2026
Sponsor: Sanmai Technologies PBC dba Sanmai
Parkinson Disease
United States
Test-retest Trial With [11C]MODAG-005 in PD or MSA and AMHC - Pilot PhaseRecruiting
NCT07640542EARLY_Phase 1Updated Jul 31, 2026
Sponsor: MODAG GmbH
Parkinson Disease (PD) · MSA - Multiple System Atrophy · Healthy Adult Participants
Germany
Automated Imaging Differentiation of ParkinsonismActive Not Recruiting
NCT05913687N/AUpdated Jul 31, 2026
Sponsor: University of Florida
Parkinson Disease · Multiple System Atrophy, Parkinson Variant · Progressive Supranuclear Palsy
United States, Canada
Genetic Studies of Lysosomal Storage DisordersEnrolling By Invitation
NCT00001215N/AUpdated Jul 31, 2026
Sponsor: National Human Genome Research Institute (NHGRI)
Lysosomal Storage Disorders · Gaucher Disease · Parkinson Disease
United States
Parkinson's Research In Metagenomic Early Stage BiomarkersNot Yet Recruiting
NCT07097103NAUpdated Jul 30, 2026
Sponsor: IRCCS San Raffaele Roma
Parkinson's Disease (PD)
Italy
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)Recruiting
NCT07252739Phase 2Updated Jul 30, 2026
Sponsor: Merck Sharp & Dohme LLC
Malignant Neoplasm
United States, Chile, China, Finland, Greece +8 more
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)Recruiting
NCT04165798N/AUpdated Jul 30, 2026
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Non-Small-Cell Lung
United States, Hungary, Israel, Italy, Poland +4 more
Music Therapy in Parkinson's DiseaseRecruiting
NCT07734181NAUpdated Jul 30, 2026
Sponsor: Siegward -M. Elsas
Parkinson's Disease (PD)
Switzerland
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseaseRecruiting
NCT06680830Phase 2Updated Jul 30, 2026
Sponsor: Neuron23 Inc.
Parkinson Disease · Parkinson · Idiopathic Parkinson Disease · Early Parkinson Disease (Early PD)
United States, Israel, Italy, Poland, Spain +1 more
Endurance Exercise & Virtual Reality for Optimizing Cortical Excitability and Neuroplasticity in PDCompleted
NCT06133283NAUpdated Jul 30, 2026
Sponsor: The University of Texas Health Science Center at San Antonio
Parkinson Disease
United States
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)Recruiting
NCT04165070Phase 1, Phase 2Updated Jul 30, 2026
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Non-Small-Cell Lung
United States, Hungary, Israel, Italy, Poland +4 more
Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)Active Not Recruiting
NCT04626518Phase 1, Phase 2Updated Jul 30, 2026
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Renal Cell
United States, Australia, Canada, Chile, France +8 more
Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)Active Not Recruiting
NCT04626479Phase 1, Phase 2Updated Jul 30, 2026
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Renal Cell
United States, Australia, Canada, Chile, Colombia +9 more
Study of Transanal Irrigation vs Standard Care for Constipation, Gut Microbiota, and Motor Disorders in Parkinson's DiseaseNot Yet Recruiting
NCT07716553NAUpdated Jul 30, 2026
Sponsor: University Hospital of Ferrara
Parkinson Disease · Constipation
Italy
Adapted Physical Activity and Tango-Based Therapy for Parkinson's Disease: A Pilot StudyCompleted
NCT07736014NAUpdated Jul 30, 2026
Sponsor: University of Foggia
Parkinson's Disease (PD)
Italy
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)Recruiting
NCT06170788Phase 3Updated Jul 30, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer (NSCLC)
United States, Argentina, Australia, Brazil, Canada +21 more
Parkinson Ballroom Fitness: The Impact of Personalized Dance on Motor- and Nonmotor Symptoms in People With Parkinson'sEnrolling By Invitation
NCT07278297NAUpdated Jul 29, 2026
Sponsor: Central Jutland Regional Hospital
Parkinson Disease (PD) · Exercise Training · Dance Therapy
Denmark
Deep Brain Stimulation in Parkinson's Disease: Motor and Functional OutcomesEnrolling By Invitation
NCT07567599NAUpdated Jul 29, 2026
Sponsor: Federal University of Minas Gerais
Parkinson Disease
Brazil
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's DiseaseRecruiting
NCT06088355NAUpdated Jul 29, 2026
Sponsor: VA Office of Research and Development
Parkinson Disease · Movement Disorders · Neurodegeneration
United States
Phase I/II Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's DiseaseNot Yet Recruiting
NCT07733349Phase 1, Phase 2Updated Jul 29, 2026
Sponsor: Shanghai UniXell Biotechnology Co., Ltd
Parkinson's Disease
China
Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson DiseaseRecruiting
NCT06638944Phase 2Updated Jul 29, 2026
Sponsor: University of Illinois at Urbana-Champaign
Dysphagia · Stroke · Parkinson Disease
United States
Remote Monitoring in Progressive Supranuclear Palsy (PSP)Not Yet Recruiting
NCT04753320N/AUpdated Jul 29, 2026
Sponsor: Massachusetts General Hospital
Progressive Supranuclear Palsy · Parkinson Disease · MSA - Multiple System Atrophy
United States
Parkinson Disease and DBS: Cognitive Effects in GBA Mutation CarriersCompleted
NCT03234478N/AUpdated Jul 29, 2026
Sponsor: Rutgers, The State University of New Jersey
Parkinson · Parkinson Disease · Genetic Predisposition · GBA Gene Mutation
United States
A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD)Not Yet Recruiting
NCT07566429Phase 2Updated Jul 29, 2026
Sponsor: Bayer
Parkinson Disease
Japan

Previous page Next page